Paper39149209
Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial.
Pane M and 1 other. Front Microbiol, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial. Papers, record 39149209. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149209
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29168557 | Probiotics for vulvovaginal candidiasis in non-pregnant women. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29168557 | PubMed |
| 2 | 25291115 | Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study. | J Clin Gastroenterol | 2014 | https://conductscience.org/library/papers/25291115 | PubMed |
| 3 | 35352028 | Tackling the emerging threat of antifungal resistance to human health. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/35352028 | PubMed |
| 4 | 38647290 | Controlling Candida: immune regulation of commensal fungi in the gut. | Infect Immun | 2024 | https://conductscience.org/library/papers/38647290 | PubMed |
| 5 | 37147720 | Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study. | Mycoses | 2023 | https://conductscience.org/library/papers/37147720 | PubMed |
| 6 | 27741167 | In Vitro Activity of Lactobacillus fermentum LF5 Against Different Candida Species and Gardnerella vaginalis: A New Perspective to Approach Mixed Vaginal Infections? | J Clin Gastroenterol | 2016 | https://conductscience.org/library/papers/27741167 | PubMed |
| 7 | 12530485 | Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar? | Infect Dis Obstet Gynecol | 2002 | https://conductscience.org/library/papers/12530485 | PubMed |
| 8 | 27741168 | The In Vitro Effectiveness of Lactobacillus fermentum Against Different Candida Species Compared With Broadly Used Azoles. | J Clin Gastroenterol | 2016 | https://conductscience.org/library/papers/27741168 | PubMed |
| 9 | 21327023 | Safety assessment of probiotics for human use. | Gut Microbes | 2010 | https://conductscience.org/library/papers/21327023 | PubMed |
| 10 | 37189681 | Antifungal Drug Resistance: An Emergent Health Threat. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189681 | PubMed |
| 11 | 33918150 | Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis. | J Clin Med | 2021 | https://conductscience.org/library/papers/33918150 | PubMed |
| 12 | 20725094 | An insight into the antifungal pipeline: selected new molecules and beyond. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20725094 | PubMed |
| 13 | 3529970 | Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Nystatin Multicenter Study Group. | Am J Obstet Gynecol | 1986 | https://conductscience.org/library/papers/3529970 | PubMed |
| 14 | 31270690 | Influence of recurrent vulvovaginal candidiasis on quality of life issues. | Arch Gynecol Obstet | 2019 | https://conductscience.org/library/papers/31270690 | PubMed |
| 15 | 36816582 | Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/36816582 | PubMed |
| 16 | 22955364 | Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. | J Clin Gastroenterol | 2012 | https://conductscience.org/library/papers/22955364 | PubMed |
| 17 | 35005777 | Treatment for recurrent vulvovaginal candidiasis (thrush). | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35005777 | PubMed |
| 18 | 14709186 | Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. | J Womens Health (Larchmt) | 2003 | https://conductscience.org/library/papers/14709186 | PubMed |
| 19 | 17560449 | Vulvovaginal candidosis. | Lancet | 2007 | https://conductscience.org/library/papers/17560449 | PubMed |
| 20 | 16790461 | Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. | J Antimicrob Chemother | 2006 | https://conductscience.org/library/papers/16790461 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42588524 | Intravaginal Formulation Strategies for Vaginal Disorders: Optimizing Phytochemical and Biological Preparations-A Review. | Molecules | 2026 | https://conductscience.org/library/papers/42588524 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39149209
GET https://conductscience.org/api/papers/v1/39149209/references?page=2